|
|
||||||||
Eur J Cardiothorac Surg 2007;31:1029-1036. doi:10.1016/j.ejcts.2007.02.016
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
a Department of Cardio-thoracic Surgery, Academic Medical Center of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
b Department of Clinical Chemistry, Academic Medical Center of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
c Department of Cardiology, Academic Medical Center of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Received 15 November 2006; received in revised form 1 February 2007; accepted 15 February 2007.
* Corresponding author. Tel.: +31 20 5662611(O)/6848555(R); fax: +31 20 6962289. (Email: J.M.vandenGoor{at}amc.uva.nl).
Objective: During cardiopulmonary bypass (CPB), systemic coagulation is believed to become activated by blood contact with the extracorporeal circuit and by retransfusion of pericardial blood. To which extent retransfusion activates systemic coagulation, however, is unknown. We investigated to which extent retransfusion of pericardial blood triggers systemic coagulation during CPB. Methods: Thirteen patients undergoing elective coronary artery bypass grafting surgery were included. Pericardial blood was retransfused into nine patients and retained in four patients. Systemic samples were collected before, during and after CPB, and pericardial samples before retransfusion. Levels of prothrombin fragment F 1+2 (ELISA), microparticles (flow cytometry) and non-cell bound (soluble) tissue factor (sTF; ELISA) were determined. Results: Compared to systemic blood, pericardial blood contained elevated levels of F 1+2, microparticles and sTF. During CPB, systemic levels of F 1+2 increased from 0.28 (0.25–0.37; median, interquartile range) to 1.10 (0.49–1.55) nmol/l (p = 0.001). This observed increase was similar to the estimated (calculated) increase (p = 0.424), and differed significantly between retransfused and non-retransfused patients (1.12 nmol/l vs 0.02 nmol/l, p = 0.001). Also, the observed systemic increases of platelet- and erythrocyte-derived microparticles and sTF were in line with predicted increases (p = 0.868, p = 0.778 and p = 0.205, respectively). Before neutralization of heparin, microparticles and other coagulant phospholipids decreased from 464 µg/ml (287–701) to 163 µg/ml (121–389) in retransfused patients (p = 0.001), indicating rapid clearance after retransfusion. Conclusion: Retransfusion of pericardial blood does not activate systemic coagulation under heparinization. The observed increases in systemic levels of F 1+2, microparticles and sTF during CPB are explained by dilution of retransfused pericardial blood.
Key Words: Cardiopulmonary bypass Coagulation Pericardial blood Microparticle Tissue factor
This article has been cited by other articles:
![]() |
J. van den Goor, B. Saxby, J. Tijssen, K. Wesnes, B. de Mol, and R Nieuwland Improvement of cognitive test performance in patients undergoing primary CABG and other CPB-assisted cardiac procedures Perfusion, September 1, 2008; 23(5): 267 - 273. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |